In vitro-generation of surrogate islets from adult stem cells.

Abstract:

:Type 1 diabetes is one of the more costly chronic diseases of children and adolescents throughout North America and Europe, exhibiting an average estimated prevalence rate of nearly 0.2%. It occurs in genetically predisposed individuals when the immune system attacks and destroys specifically the insulin-producing beta cells of the pancreatic islets of Langerhans. While routine insulin therapy can provide diabetic patients with their daily insulin requirements, non-compliance and undetected hyperglycemic excursions often lead to subsequent long-term microvascular and macrovascular complications. The only real cure for type 1 diabetes is replacement of the beta cell mass, currently being accomplished through ecto-pancreatic transplantation and islet implantation. Both of these procedures suffer from a chronic shortage of available donor tissue in comparison to the number of potential recipients. To circumvent this need, three alternative approaches are being intensively investigated: (1) the production of surrogate cells by genetically modifying non-endocrine cells to secrete insulin in response to glucose challenge; (2) the trans-differentiation of non-endocrine stem/progenitor cells or mature cells to glucose-responsive adult tissue; and (3) the regulated differentiation of islet stem/progenitor cells to produce large numbers of mature, functional islets. In recent years, each of these approaches has made impressive advances, leading to the most important question, 'how soon will this new science be available to the patient?' In the present review, we discuss some of the recent advances, focusing primarily on the differentiation of islet stem cells to functional endocrine pancreas that may form the basis for future treatment.

journal_name

Transpl Immunol

journal_title

Transplant immunology

authors

Peck AB,Ramiya V

doi

10.1016/j.trim.2003.12.011

subject

Has Abstract

pub_date

2004-04-01 00:00:00

pages

259-72

issue

3-4

eissn

0966-3274

issn

1878-5492

pii

S0966-3274(03)00109-6

journal_volume

12

pub_type

杂志文章,评审
  • Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.

    abstract::Mycophenolate mofetil (MMF) a potent immunosuppressive agent, has recently been approved for clinical use (CellCept) in renal transplant patients in combination with cyclosporine (CsA). With the expanded use of tacrolimus (Prograf) as well in renal transplant patients, there is a lack of pharmacokinetic studies clarif...

    journal_title:Transplant immunology

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0966-3274(97)80042-1

    authors: Zucker K,Rosen A,Tsaroucha A,de Faria L,Roth D,Ciancio G,Esquenazi V,Burke G,Tzakis A,Miller J

    更新日期:1997-09-01 00:00:00

  • Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.

    abstract::The containment of direct and indirect recognition of donor alloantigens by enhancement of the number and activity of regulatory T cells (Tregs) has been one of the promising approaches to achieve transplant tolerance. Two major methods, dendritic cell (DC) and anti-CD3/CD28 antibodies (Abs) have been introduced for e...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2009.07.004

    authors: Zeng M,Guinet E,Nouri-Shirazi M

    更新日期:2009-12-01 00:00:00

  • Antibody-mediated activation of the classical complement pathway in xenograft rejection.

    abstract::Transplant rejection is a multifactorial process involving complex interactions between components of the innate and the acquired immune system. In view of the shortage of donor organs available for transplantation, xenotransplantation of pig organs into man has been considered as a potential solution. However, in com...

    journal_title:Transplant immunology

    pub_type: 杂志文章,评审

    doi:10.1016/s0966-3274(02)00042-4

    authors: Roos A,Daha MR

    更新日期:2002-05-01 00:00:00

  • Eosinophils in acute renal allograft rejection.

    abstract::Tissue eosinophils have been previously implicated in allograft rejection and graft loss. The aim of this study was to evaluate the role of eosinophils in acute renal allograft rejection. Data from 71 patients with 114 renal biopsies with acute allograft rejection were compared with those from 26 controls. The median ...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/0966-3274(94)90076-0

    authors: Hongwei W,Nanra RS,Stein A,Avis L,Price A,Hibberd AD

    更新日期:1994-01-01 00:00:00

  • Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era.

    abstract:AIM:To identify the frequency of exposure to sensitizing factors and evaluate the risk ascribable to each sensitizing factor generating HLAabs measured by Luminex. METHODS:This is a retrospective cohort study that included 502 transplanted patients and 51 patients on the waiting list for a deceased donor graft. Patien...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2016.08.003

    authors: Guichard-Romero A,Marino-Vazquez LA,Castelán N,López M,González-Tableros N,Arvizu A,De Santiago A,Alberú J,Morales-Buenrostro LE

    更新日期:2016-09-01 00:00:00

  • Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.

    abstract::It is known that the expression level of the heat shock protein (HSP) is elevated in allograft tissues, but the specific role of the HSP in the acute rejection has not been elucidated. This study aims to determine how and when the HSP72 molecule works immunologically in the process of acute allograft rejection from a ...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2004.08.003

    authors: Oh KH,Kim JY,Kim D,Lee EM,Oh HY,Seo JS,Han JS,Kim S,Lee JS,Ahn C

    更新日期:2004-12-01 00:00:00

  • Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?

    abstract::Humoral rejection and its relationship with anti HLA antibodies have been extensively studied in organ transplantation with the exception of liver transplantation (LT). Recently, association between donor specific anti HLA antibodies (DSA) and increased risk of rejection and graft loss has been suggested in LT. When s...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2016.01.007

    authors: Ducreux S,Guillaud O,Bosch A,Thaunat O,Morelon E,Hervieu V,Mekki Y,Boillot O,Scoazec JY,Dubois V,Dumortier J

    更新日期:2016-03-01 00:00:00

  • Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.

    abstract:OBJECTIVE:The immunomodulator, FTY720, lowers the peripheral lymphocyte count (PLC) by inducing migration of circulating lymphocytes to secondary lymphoid organs. We investigated the efficacy of mono- vs. combined-FTY720/CsA therapy on graft survival (GS) and on lowering the PLC in a solid organ and a skin graft model,...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/s0966-3274(01)00031-4

    authors: Nikolova Z,Hof A,Baumlin Y,Hof RP

    更新日期:2001-02-01 00:00:00

  • Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

    abstract::Alloreactive T-cell responses directed against minor histocompatibility (H) antigens, which arise from diverse genetic disparities between donor and recipient outside the MHC, are an important cause of rejection of MHC-matched grafts. Because clinically significant responses appear to be directed at only a few antigen...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2013.10.005

    authors: Hess SM,Young EF,Miller KR,Vincent BG,Buntzman AS,Collins EJ,Frelinger JA,Hess PR

    更新日期:2013-12-01 00:00:00

  • A modified splint tubing technique for heterotopic heart transplantation in mouse.

    abstract:BACKGROUND:The complexity of surgical procedure in mouse heterotopic heart transplantation (HHT) has prevented its widespread use. The present study reported a modified technique - splint tubing technique (STT) based on cuff technique (CT). MATERIALS AND METHODS:C57BL/10 and BALB/c mice were performed in syngeneic and...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2011.03.005

    authors: Li C,Luo L,Lu J,Feng L,Shan J,Long D,Guo Y,Wu W,Li S,Li Y

    更新日期:2011-07-01 00:00:00

  • Tim-3 expression in human kidney allografts.

    abstract:BACKGROUND:Tim-3 was recently described as a Th1-specific molecule, participating in the regulation of immune responses and in the induction of allograft tolerance. Here, we studied Tim-3 mRNA expression together with molecular markers of T-cell activation and cytotoxicity, in rejected human kidney grafts. METHODS:Twe...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2006.11.003

    authors: Ponciano VC,Renesto PG,Nogueira E,Rangel EB,Cenedeze MA,Franco MF,Câmara NO,Pacheco-Silva A

    更新日期:2007-04-01 00:00:00

  • Manipulation of skin graft rejection in alloimmune mice by anti-VCAM-1:VLA-4 but not anti-ICAM-1:LFA-1 monoclonal antibodies.

    abstract::C3H mice were immunized by repeated skin grafting with B10.BR tail skin. Ten days after the last immunization mice received 100 micrograms (intravenously) of a variety of different monoclonal antibodies (mAbs: anti-ICAM-1, -LFA-1, -VCAM-1, -VLA-4), alone or in combination, followed by further B10.BR skin grafts. Contr...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/0966-3274(95)80007-7

    authors: Gorcyznski RM,Chung S,Fu XM,Levy G,Sullivan B,Chen Z

    更新日期:1995-03-01 00:00:00

  • Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.

    abstract::The gene expression of the cytotoxic T-cell molecules perforin, granzyme B and Fas ligand are associated with acute rejection in renal allograft recipients. Several immune mechanisms are linked to severe systemic inflammation in brain-dead organ donors. We examined the mRNA expression of these T-cell activation biomar...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2008.12.002

    authors: Carstens J,Ozbay A,Tørring C,Hansen HE

    更新日期:2009-03-01 00:00:00

  • Inflammatory immune responses in a reproducible mouse brain death model.

    abstract:BACKGROUND:Brain death impairs donor organ quality and accelerates immune responses after transplantation. Detailed aspects of immune activation following brain death remain unclear. We have established a mouse model and investigated the immediate consequences of brain death and anesthesia on immune responses. METHODS...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2012.04.002

    authors: Floerchinger B,Yuan X,Jurisch A,Timsit MO,Ge X,Lee YL,Schmid C,Tullius SG

    更新日期:2012-08-01 00:00:00

  • T cell costimulation blockade for hyperacute steroid refractory graft versus-host disease in children undergoing haploidentical transplantation.

    abstract::The outcome of hyperacute grade 3-4 steroid-refractory graft-versus-host-disease (SR-GVHD) remains dismal despite a plethora of agents being tried alone or in combination. Following T replete haploidentical transplantation with post-transplantation cyclophosphamide on 75 patients, 10 patients (13%) aged 2-20years, dev...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2016.08.009

    authors: Jaiswal SR,Zaman S,Chakrabarti A,Sehrawat A,Bansal S,Gupta M,Chakrabarti S

    更新日期:2016-11-01 00:00:00

  • Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.

    abstract::Adoptive cell therapies involving cell manipulation to achieve tolerance are increasingly being studied in animal models and in human trials. We have demonstrated that the specific removal of allo-stimulated dividing cells (or "pruning") promotes long-term allograft survival across a major MHC mismatch in transplant m...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2014.03.002

    authors: Watson D,Zhang GY,Hu M,Wang YM,Fletcher J,Sartor M,Alexander SI

    更新日期:2014-05-01 00:00:00

  • Impact of HLA polymorphisms among cadaveric donors on kidney graft allocation.

    abstract::This study provides data on HLA-A, -B, and -DRB1 frequencies among 861 end-stage renal disease (ESRD) patients from Croatia and estimates the benefit of the kidney exchange program by comparing HLA distribution and assessing HLA mismatches (MMs) within a group of ESRD patients who received kidney grafts from 707 cadav...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2020.101318

    authors: Grubic Z,Burek Kamenaric M,Kljajic J,Stingl Jankovic K,Maskalan M,Zunec R

    更新日期:2020-10-01 00:00:00

  • Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.

    abstract::In recent years, the utility of vascular complement factor 4d (C4d) deposition as diagnostic tool for antibody mediated rejection (AMR) after lung transplantation, has become a controversial issue. We aimed to pinpoint the problematic nature of C4d as biomarker with a simple experiment. We quantified C4d in broncho-al...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2020.101352

    authors: Heigl T,Saez-Gimenez B,Van Herck A,Kaes J,Sacreas A,Beeckmans H,Ambrocio GPL,Kwakkel-Van Erp H,Ordies S,Vanstapel A,Verleden SE,Neyrinck AP,Ceulemans LJ,Van Raemdonck DE,Verbeken E,Verleden GM,Vos R,Vanaudenaerde B

    更新日期:2021-02-01 00:00:00

  • Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.

    abstract::Graft rejection and graft-versus-host disease are leading causes of transplant related mortality despite advancements in immunosuppressive therapy. Mesenchymal stem cells (MSCs) offer a promising addition to immunosuppressive drugs (ISD), while NK-cells are increasingly used as effector cells in graft-versus-leukemia....

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2016.04.008

    authors: Michelo CM,Fasse E,van Cranenbroek B,Linda K,van der Meer A,Abdelrazik H,Joosten I

    更新日期:2016-07-01 00:00:00

  • HMGB1 blockade significantly improves luminal fibrous obliteration in a murine model of bronchiolitis obliterans syndrome.

    abstract:BACKGROUND:Although high-mobility group box-1 (HMGB1), which is a nuclear protein, was reported to enhance the allogeneic responses in transplantation, the effect of HMGB1 on bronchiolitis obliterans syndrome (BOS) is unknown. METHODS:A murine heterotopic tracheal transplantation model was used. Protein concentrations...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2018.11.007

    authors: Takamori S,Shoji F,Okamoto T,Kozuma Y,Matsubara T,Haratake N,Akamine T,Katsura M,Takada K,Toyokawa G,Tagawa T,Maehara Y

    更新日期:2019-04-01 00:00:00

  • Long-term engraftment of precultured post-5-fluorouracil allogeneic marrow in mice conditioned with a nonmyeloablative regimen: relevance for a gene therapy approach to tolerance induction.

    abstract::Introduction of MHC class I Kb cDNA via recombinant retrovirus into B10.AKM (Kk) bone marrow cells (BMC) has been shown to confer specific hyporesponsiveness to B10.MBR (Kb) allogeneic skin grafts in lethally irradiated B10.AKM recipients of the transduced syngeneic BMC. We have recently developed a nonmyeloablative c...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/s0966-3274(96)80044-x

    authors: Hayashi H,LeGuern C,Sachs DH,Sykes M

    更新日期:1996-03-01 00:00:00

  • mir-155 expression is downregulated in kidney transplant patients with human cytomegalovirus infection.

    abstract::MicroRNAs are small, noncoding RNAs that control expression of target genes through inhibiting protein translation or inducing degradation of mRNA transcripts of target genes. According to the latest update, 2578 unique mature miRNAs are currently annotated in the human genome and participate in the regulation of mult...

    journal_title:Transplant immunology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.trim.2017.06.002

    authors: Bergallo M,Gambarino S,Montanari P,Daprà V,Rassu M,Galliano I,Ravanini P

    更新日期:2017-08-01 00:00:00

  • Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.

    abstract::Adenoviral gene transfer is a potential ex vivo gene therapy for islet transplantation. However, the immunogenicity of adenoviral vectors can potentially impair vector efficacy in transplants where long-term gene expression is required. We investigated the effect of this antiviral immunity on vector expression and isl...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2009.02.001

    authors: Cheng J,Sun J,Sung RS

    更新日期:2009-05-01 00:00:00

  • Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.

    abstract:BACKGROUND:B cell depletion by anti-CD20 antibody is used in desensitization protocols and for treatment of antibody-mediated rejection (AMR). However, little is known about the efficacy and the mechanism(s) of action. METHODS:A mouse model of HLA sensitization was used to study the effectiveness of anti-CD20 treatmen...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2008.05.004

    authors: Wu GD,He Y,Chai NN,Toyoda M,Dunn R,Kehry MR,Klein AS,Jordan SC

    更新日期:2008-07-01 00:00:00

  • Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.

    abstract:BACKGROUND:Donor leucocytes (DL) play an important role in rat liver transplant tolerance and their postoperative administration can convert rejection to tolerance. They appear to induce early activation, altered patterns of infiltration and death of recipient alloreactive T cells. The ability of immunosuppressive drug...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2004.05.003

    authors: den Dulk M,Wang C,Li J,Clark DA,Hibberd AD,Terpstra OT,McCaughan GW,Bishop GA

    更新日期:2004-11-01 00:00:00

  • Methotrexate regulates ICAM-1 expression in recipients of rat cardiac allografts.

    abstract::The means by which methotrexate (MTX) mediates immunosuppression at low doses remains to be elucidated. MTX has been shown to inhibit the adherence of neutrophils and fibroblasts to endothelial cells in vitro. The hypothesis that MTX treatment may affect cellular adherence by downregulating cell adhesion molecule expr...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/s0966-3274(98)80026-9

    authors: Ciesielski CJ,Pflug JJ,Mei J,Piccinini LA

    更新日期:1998-06-01 00:00:00

  • Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs.

    abstract:BACKGROUND AND PURPOSE:Since the Fas/Fas Ligand (FasL) interaction has been recognized as an apoptotic pathway, it eliminates the activated T cells and promotes the survival of grafts. In this study, the effect of FasL transfection of pig chondrocytes on allogeneic transplantation was examined in vitro and in vivo. ME...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2008.02.001

    authors: Xie GH,Wang SJ,Wang Y,Zhang Y,Zhang HZ,Jin S,Wang QF,Liu ZC,Ge HL

    更新日期:2008-05-01 00:00:00

  • Impact of rituximab on the T-cell flow cytometric crossmatch.

    abstract::Rituximab is frequently used in the setting of ABO-incompatible renal transplants, and highly sensitized patients. Its interference with B-cell flow cytometric crossmatch (B-FCXM) is well known. However, its effect on the T-cell flow cytometric crossmatch (T-FCXM) has not been described. We aimed to evaluate the effec...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2020.101360

    authors: Doss SA,Mittal S,Daniel D

    更新日期:2021-02-01 00:00:00

  • Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.

    abstract::Models of severe combined immuno-deficient (SCID) mice reconstituted with a competent human immune system represent a valuable tool for the study of human immune responses in vivo. Reconstitution with human cells can be achieved using large numbers of peripheral blood lymphocytes, but levels of engraftment are poor an...

    journal_title:Transplant immunology

    pub_type: 杂志文章

    doi:10.1016/j.trim.2005.07.002

    authors: Yacoub-Youssef H,Marcheix B,Calise D,Thiers JC,Therville N,Benoist H,Blaes N,Ségui B,Dambrin C,Thomsen M

    更新日期:2005-12-01 00:00:00

  • A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.

    abstract::Immunisation against Human Leucocyte Antigens (HLA) can be caused by pregnancy, blood transfusion, or organ transplants. The HLA antibody status of a given patient significantly influences their access and waiting time to transplant. For some highly sensitised patients (HSP) there is hardly any suitable donor availabl...

    journal_title:Transplant immunology

    pub_type: 社论

    doi:10.1016/j.trim.2020.101354

    authors: Mumford L,Fuggle SV,Martorell J,Slavcev A,Iniotaki A,Haasnoot GW,Heidt S,Claas FHJ

    更新日期:2021-02-01 00:00:00